日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials

双重 RAAS 阻断和强化降压治疗对常染色体显性多囊肾病终末期肾病和死亡风险的影响:HALT-PKD 试验的长期随访

Ku, Elaine; Copeland, Timothy P; McCulloch, Charles E; Abebe, Kaleab Z; Chonchol, Michel; Perrone, Ronald D; Rahbari-Oskoui, Frederic F; Yu, Alan S L; Steinman, Theodore; Chapman, Arlene; Sarnak, Mark J

ADPKD Progression by Variant Type and Molecular Domain Among Participants in the HALT PKD Trial

HALT PKD试验参与者中ADPKD按变异类型和分子结构域划分的进展情况

Sucholeiki, Robert L; Jochum, Elena; Chen, Peili; Wessely, Oliver; Galasinski, Shelly; Chapman, Arlene B

Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney Disease

种族对常染色体显性多囊肾病移植的影响

Krishnamoorthy, Sambhavi; Satishchandra, Niveditha Girimaji; Chapman, Arlene; McGill, Rita

Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease

超重、肥胖与常染色体显性多囊肾病患者进展至终末期肾病的关系

Nowak, Kristen L; Copeland, Timothy P; Ku, Elaine; Sarnak, Mark J; Gitomer, Berenice; Abebe, Kaleab Z; Chapman, Arlene; Perrone, Ronald; Rahbari-Oskoui, Frederic F; Steinman, Theodore; Yu, Alan S L; Chonchol, Michel

Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD

验证 SONG-PKD 疼痛量表,该量表是 ADPKD 疼痛的核心结局指标

Cazzolli, Rosanna; Ju, Angela; Natale, Patrizia; Teixeira-Pinto, Armando; Howell, Martin; Jaure, Allison; Perrone, Ronald D; Burnette, Eva; Casteleijn, Niek F; Chapman, Arlene; Craig, Jonathan C; Eastty, Sarah; Gansevoort, Ron T; Harris, Tess; Hogan, Marie C; Horie, Shigeo; Knebelmann, Bertrand; Lee, Richard; Manera, Karine; Mustafa, Reem A; Sandford, Richard; Rangan, Gopala K; Sautenet, Bénédicte; Viecelli, Andrea K; Cho, Yeoungjee

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy

临床药物遗传学实施联盟关于NAT2基因型和肼屈嗪治疗的指南

Eadon, Michael T; Hein, David W; Andersen, Michael A; Chapman, Arlene B; Cooper-DeHoff, Rhonda M; Desta, Zeruesenay; Duarte, Julio D; Elchynski, Amanda L; Gaedigk, Andrea; Karol, Seth E; Limdi, Nita A; Lteif, Christelle; Sosinski, Laura; Zubiaur, Pablo; Whirl-Carrillo, Michelle; Klein, Teri E; Caudle, Kelly E; Donnelly, Roseann S; Agúndez, José A G

SAT-523 Patient Education Reduces Rates Of Dka For Populations On Sglt2i

SAT-523 患者教育可降低接受 Sglt2i 治疗人群的糖尿病酮症酸中毒发生率

Wynne, Brandi M; McCarthy, Cameron G; Szasz, Theodora; Molina, Patrick A; Chapman, Arlene B; Webb, R Clinton; Klein, Janet D; Hoover, Robert S; Hoyt, Jonah A; Gross, Elena S; Au, Loretta; Imas, Polina; Block, Romy Jill

Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program

常染色体显性多囊肾病卓越中心计划的使命和未来规划

Hoover, Elise; Cambareri, Heidi; Chapman, Arlene B; Chebib, Fouad T; Moore, Savanna; Perrone, Ronald D; Garimella, Pranav S

Transitional Care Units in the United States: A Model for Improving Dialysis Care

美国过渡护理单元:改善透析护理的模式

Baeseman, Louis G; Gunning, Samantha; Reddy, Bharathi V; McGill, Rita L; Chapman, Arlene B

Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension

利钠肽信号通路中的心脏局部多囊蛋白-2与高血压

Márquez-Nogueras, Karla M; Elliott, Brandon; Thuo, Paula; DiNello, Elisabeth; Knutila, Ryne M; Fritzmann, Geena E; Vuchkovska, Virdjinija; Flury, Sarah; Willis, Monte; Chapman, Arlene B; Cao, Quan; Barefield, David Y; Kuo, Ivana Y